Clinical Trial Update: Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating whether supplementation with vitamin D3 and yeast beta-glucan improves glycemic control and lowers cardiovascular risk in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vitamin D3 (Cholecalciferol)
• Yeast beta-glucan (beta-glucan (yeast-derived))

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Diabetes Mellitus, Type 2 | NA | Status: RECRUITING